Evaluation of TMN classification for lung carcinoma with ipsilateral intrapulmonary metastasis

Citation
M. Okada et al., Evaluation of TMN classification for lung carcinoma with ipsilateral intrapulmonary metastasis, ANN THORAC, 68(2), 1999, pp. 326-330
Citations number
18
Categorie Soggetti
Cardiovascular & Respiratory Systems","Medical Research Diagnosis & Treatment
Journal title
ANNALS OF THORACIC SURGERY
ISSN journal
00034975 → ACNP
Volume
68
Issue
2
Year of publication
1999
Pages
326 - 330
Database
ISI
SICI code
0003-4975(199908)68:2<326:EOTCFL>2.0.ZU;2-J
Abstract
Background. Staging for lung cancer based on the TNM classification is an i mportant predictive factor for prognosis. Recently, lung cancer with ipsila teral intrapulmonary metastasis (PM) was reclassified according to the revi sion of the TNM classification. To evaluate the prognostic importance of th e new staging system for PM, we analyzed the postoperative survival of pati ents with non-small cell lung carcinoma. Methods. Of 1,002 consecutive patients who underwent operation for primary lung cancer between Tune 1984 and December 1996, we reviewed the medical re cord of 889 patients who underwent complete resection for nonsmall cell lun g cancer. Results. We considered 89 patients (10.0%) to have synchronous ipsilateral PM. After reclassification to the former staging system revised in 1995 5 p atients were classified as stage I, 29 as stage IIIA, 48 as stage IIIB, and 7 as stage IV. In the new staging system revised in 1997, 48 patients were recategorized as stage IIIB, and 41 as stage TV. The 5-year survival of pa tients without PM (49.5%) was significantly better than that of patients wi th PM in primary-tumor lobe (29.6%, p = 0.002) or in nonprimary-tumor ipsil ateral lobe (23.4%, p = 0.0002). Although the survival of patients with sta ge IV cancer without PM was significantly worse than that of patients with the new (1997) stage IV cancer with PM (p = 0.02), it was similar to that o f patients with the former (1992) stage IV cancer with PM. The survival of PM patients with N0 or N1 disease was significantly better than that of PM patients with N2 or N3 disease (p = 0.001). Furthermore, in patients with t he new (1997) stage IIIB cancer, the survival of N0 disease was better than that of N2 disease (p = 0.007). Conclusions. Inasmuch as the prognosis of non-small cell carcinoma in patie nts with PM strongly correlated with N factor rather than PM factor, N fact or should be reflected in a staging designation. We therefore consider the new TNM classification for PM reclassified in 1997 to be less acceptable fo r surgical-pathologic staging than the revision in 1992. (C) 1999 by The So ciety of Thoracic Surgeons.